HMGB1 and stroke disorder: Our results suggested that the polymer-drug conjugate nanoparticles could effectively alleviate the pathology of stroke, reduce infarct volume, and enhance neurogenesis, through inhibiting HMGB1 translocation and switching microglia M1 or M2 phenotype.